128 related articles for article (PubMed ID: 20580638)
1. Dimerization drives PDGF receptor endocytosis through a C-terminal hydrophobic motif shared by EGF receptor.
Pahara J; Shi H; Chen X; Wang Z
Exp Cell Res; 2010 Aug; 316(14):2237-50. PubMed ID: 20580638
[TBL] [Abstract][Full Text] [Related]
2. Identification of EGF receptor C-terminal sequences 1005-1017 and di-leucine motif 1010LL1011 as essential in EGF receptor endocytosis.
Wang Q; Zhu F; Wang Z
Exp Cell Res; 2007 Sep; 313(15):3349-63. PubMed ID: 17643422
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.
Lipson KE; Pang L; Huber LJ; Chen H; Tsai JM; Hirth P; Gazit A; Levitzki A; McMahon G
J Pharmacol Exp Ther; 1998 May; 285(2):844-52. PubMed ID: 9580635
[TBL] [Abstract][Full Text] [Related]
4. Pool of ligand-bound platelet-derived growth factor beta-receptors remain activated and tyrosine phosphorylated after internalization.
Sorkin A; Eriksson A; Heldin CH; Westermark B; Claesson-Welsh L
J Cell Physiol; 1993 Aug; 156(2):373-82. PubMed ID: 7688373
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of growth factor-mediated tyrosine phosphorylation in vascular smooth muscle by PD 089828, a new synthetic protein tyrosine kinase inhibitor.
Dahring TK; Lu GH; Hamby JM; Batley BL; Kraker AJ; Panek RL
J Pharmacol Exp Ther; 1997 Jun; 281(3):1446-56. PubMed ID: 9190882
[TBL] [Abstract][Full Text] [Related]
6. Increased mitogenicity of an alphabeta heterodimeric PDGF receptor complex correlates with lack of RasGAP binding.
Ekman S; Thuresson ER; Heldin CH; Rönnstrand L
Oncogene; 1999 Apr; 18(15):2481-8. PubMed ID: 10229199
[TBL] [Abstract][Full Text] [Related]
7. Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection.
Soroceanu L; Akhavan A; Cobbs CS
Nature; 2008 Sep; 455(7211):391-5. PubMed ID: 18701889
[TBL] [Abstract][Full Text] [Related]
8. Specific locations of hydrophilic amino acids in constructed transmembrane ligands of the platelet-derived growth factor beta receptor.
Freeman-Cook LL; Edwards AP; Dixon AM; Yates KE; Ely L; Engelman DM; Dimaio D
J Mol Biol; 2005 Jan; 345(4):907-21. PubMed ID: 15588835
[TBL] [Abstract][Full Text] [Related]
9. Endocytosis of EGFR requires its kinase activity and N-terminal transmembrane dimerization motif.
Heukers R; Vermeulen JF; Fereidouni F; Bader AN; Voortman J; Roovers RC; Gerritsen HC; van Bergen En Henegouwen PM
J Cell Sci; 2013 Nov; 126(Pt 21):4900-12. PubMed ID: 23943881
[TBL] [Abstract][Full Text] [Related]
10. PDGF-D, a new protease-activated growth factor.
LaRochelle WJ; Jeffers M; McDonald WF; Chillakuru RA; Giese NA; Lokker NA; Sullivan C; Boldog FL; Yang M; Vernet C; Burgess CE; Fernandes E; Deegler LL; Rittman B; Shimkets J; Shimkets RA; Rothberg JM; Lichenstein HS
Nat Cell Biol; 2001 May; 3(5):517-21. PubMed ID: 11331882
[TBL] [Abstract][Full Text] [Related]
11. The PDGF receptor alpha subunit activates p21ras and triggers DNA synthesis without interacting with rasGAP.
Bazenet CE; Kazlauskas A
Oncogene; 1994 Feb; 9(2):517-25. PubMed ID: 8290262
[TBL] [Abstract][Full Text] [Related]
12. Identification of residues in the beta platelet-derived growth factor receptor that confer specificity for binding to phospholipase C-gamma 1.
Larose L; Gish G; Shoelson S; Pawson T
Oncogene; 1993 Sep; 8(9):2493-9. PubMed ID: 7689724
[TBL] [Abstract][Full Text] [Related]
13. In vitro pharmacological characterization of PD 166285, a new nanomolar potent and broadly active protein tyrosine kinase inhibitor.
Panek RL; Lu GH; Klutchko SR; Batley BL; Dahring TK; Hamby JM; Hallak H; Doherty AM; Keiser JA
J Pharmacol Exp Ther; 1997 Dec; 283(3):1433-44. PubMed ID: 9400019
[TBL] [Abstract][Full Text] [Related]
14. The alpha PDGFR tyrosine kinase mediates locomotion of two different cell types through chemotaxis and chemokinesis.
Uren A; Yu JC; Gholami NS; Pierce JH; Heidaran MA
Biochem Biophys Res Commun; 1994 Oct; 204(2):628-34. PubMed ID: 7980524
[TBL] [Abstract][Full Text] [Related]
15. The involvement of platelet-derived growth factor receptors and insulin-like growth factor-I receptors signaling during mineralized nodule formation by human periodontal ligament cells.
Nemoto E; Shimonishi M; Nitta Y; Shimauchi H
J Periodontal Res; 2004 Dec; 39(6):388-97. PubMed ID: 15491343
[TBL] [Abstract][Full Text] [Related]
16. Control of epidermal growth factor receptor endocytosis by receptor dimerization, rather than receptor kinase activation.
Wang Q; Villeneuve G; Wang Z
EMBO Rep; 2005 Oct; 6(10):942-8. PubMed ID: 16113650
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine kinase activity of purified recombinant cytoplasmic domain of platelet-derived growth factor beta-receptor (beta-PDGFR) and discovery of a novel inhibitor of receptor tyrosine kinases.
Zaman GJ; Vink PM; van den Doelen AA; Veeneman GH; Theunissen HJ
Biochem Pharmacol; 1999 Jan; 57(1):57-64. PubMed ID: 9920285
[TBL] [Abstract][Full Text] [Related]
18. Non-Ligand-Induced Dimerization is Sufficient to Initiate the Signalling and Endocytosis of EGF Receptor.
Kourouniotis G; Wang Y; Pennock S; Chen X; Wang Z
Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27463710
[TBL] [Abstract][Full Text] [Related]
19. Functional importance of platelet-derived growth factor (PDGF) receptor extracellular immunoglobulin-like domains. Identification of PDGF binding site and neutralizing monoclonal antibodies.
Lokker NA; O'Hare JP; Barsoumian A; Tomlinson JE; Ramakrishnan V; Fretto LJ; Giese NA
J Biol Chem; 1997 Dec; 272(52):33037-44. PubMed ID: 9407086
[TBL] [Abstract][Full Text] [Related]
20. A single amino acid substitution in a WW-like domain of diverse members of the PDGF receptor subfamily of tyrosine kinases causes constitutive receptor activation.
Irusta PM; DiMaio D
EMBO J; 1998 Dec; 17(23):6912-23. PubMed ID: 9843497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
